Guest: Samantha Cobb
Presenter: Tabetha Moreto
Guest Bio: Samantha “Sam” Cobb is the founding CEO of AdAlta. She has over 15 years’ experience in business development and commercialisation of early stage scientific technologies. As the founding CEO of AdAlta, she has raised over $20m in capital from angel investors and venture capital. Samantha was also involved in taking AdAlta public on the ASX, raising $10m in an oversubscribed IPO. Prior to AdAlta, Samantha was the Business Development Director at the Co-operative Research Centre for Diagnostics. She has also worked for the biotech start-up companies Sensologix Inc and Nephrogenix Pty Ltd, and at the University of Queensland’s technology commercialisation companies Uniquest Pty Ltd and IMBcom Pty Ltd.
Segment Overview: In today’s interview, Sam Cobb joins the programs to talk about her company. AdAlta is a highly innovative drug discovery and development company using its powerful technology platform to generate a promising new class of protein therapeutics for treating a wide range of diseases.